Drugs Rarely Become Available In Lower-Income Countries Where They’re Tested, Study Says
TUESDAY, Nov. 18, 2025 (HealthDay News) — Pharmaceutical companies are using the citizens of lower-income countries as guinea pigs to test cutting-edge drugs headed mainly for the United States and other well-off nations, a new study says. Only a quarter of medicines tested in other countries wound up available toContinue Reading










